Are you using real-world evidence?

Parexel’s experts offer a roadmap and best practices for current RWE applications across three development arenas:

  • Early asset planning
  • Clinical development: Meeting regulatory expectations
  • Medical marketplace: Demonstrating value in the real world

In each section of this playbook, we highlight examples of recent Parexel projects that illustrate the power of RWE to improve decision-making and to drive cost- and times-saving development strategies.


Open PDF

Return to Insights Center

Related Insights

Whitepaper

Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews

Mar 15, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Article

Lessons from China and the United States on the use of RWE in regulatory submissions

Jul 19, 2021

Article

How biotechs can strengthen their value story with advanced analytics

Feb 15, 2022

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Article

New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

May 10, 2022

Blog

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

May 16, 2022

Podcast

RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry

Jun 16, 2022

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Webinar

Use of AI to develop health economic evidence for optimized patient access

Sep 6, 2023

Blog

Using ethical AI to streamline HEOR

Jan 26, 2024